Simvastatin mitigates diabetic nephropathy by upregulating farnesoid X receptor and Nrf2/HO-1 signaling and attenuating oxidative stress and inflammation in rats
Iman H. Hasan, Sameerah Shaheen, Ahlam M. Alhusaini, Ayman M. Mahmoud
Topics & Concepts
Oxidative stressDiabetic nephropathySimvastatinMedicineKidneyInflammationFibrosisPharmacologyFarnesoid X receptorMalondialdehydeEndocrinologyKEAP1Internal medicineDiabetes mellitusChemistryNuclear receptorBiochemistryTranscription factorGenePeroxisome Proliferator-Activated ReceptorsInflammatory mediators and NSAID effectsLipoproteins and Cardiovascular Health